SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-18-020336
Filing Date
2018-11-09
Accepted
2018-11-09 17:23:34
Documents
54
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q inbp20180930_10q.htm 10-Q 711255
2 EXHIBIT 31.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex_127844.htm EX-31.1 13462
3 EXHIBIT 31.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex_127845.htm EX-31.2 14197
4 EXHIBIT 32.1 CERTIFICATION OF PERIODIC REPORT - CEO ex_127846.htm EX-32.1 9081
5 EXHIBIT 32.2 CERTIFICATION OF PERIODIC REPORT - CFO ex_127847.htm EX-32.2 6916
  Complete submission text file 0001437749-18-020336.txt   4116913

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT inbp-20180930.xml EX-101.INS 893299
7 XBRL TAXONOMY EXTENSION SCHEMA inbp-20180930.xsd EX-101.SCH 45692
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inbp-20180930_cal.xml EX-101.CAL 35089
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inbp-20180930_def.xml EX-101.DEF 289328
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE inbp-20180930_lab.xml EX-101.LAB 241274
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inbp-20180930_pre.xml EX-101.PRE 307498
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31668 | Film No.: 181174174
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1